Clinical trial
Efficacy and Safety,Long-term Study of Low-dose Oral Contraceptive Pill to Treat…
NCT00212277 · Nobelpharma, Industry · Completed
Key facts
| NCT number | NCT00212277 |
|---|---|
| Title | Efficacy and Safety,Long-term Study of Low-dose Oral Contraceptive Pill to Treat Dysmenorrhea. |
| Official title | Phase3,Open-label,Long-term,NSAID-Add-on,Clinical Trial of Mono-phase Low-dose Oral Contraceptive Pill for Treatment of Dysmenorrhea Associated With Endometriosis. |
| Lead sponsor | Nobelpharma, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Dysmenorrhea |
| Intervention type | Drug |
| Interventions | Norethindrone, Ethinyl Estradiol |
| Start date | Feb 1, 2005 |
| Primary completion | Sep 1, 2006 |
| Completion | Feb 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | Sep 10, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: